optimizing adjuvant treatment in hr /her2- early breast cancer
Published 2 years ago • 130 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
1:19
optimizing adjuvant therapy: chemotherapy necessity in hr-positive breast cancer
-
4:12
optimizing treatment in patients with early-stage her2-positive breast cancer
-
2:23
natalee: ribociclib nsai as adjuvant treatment in patients with hr /her2− early breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
27:11
optimizing adjuvant treatment of early breast cancer: where are we today?
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
-
3:30
final results from pallas: adjuvant palbociclib in hr /her2- early breast cancer
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
30:20
optimizing adjuvant endocrine therapy for early breast cancer
-
47:29
optimizing therapy in her2 disease with dr. reshma mahtani
-
2:10
monarche: adjuvant abemaciclib endocrine therapy in patients with hr , her2- high-risk ebc
-
1:31
mirador: monitoring mrd using ctdna in hr /her2- early breast cancer
-
4:16
adjuvant treatment for stage i her2 breast cancer
-
0:59
dr. muss on optimizing adjuvant treatment for older breast cancer patients
-
1:49
early breast cancer: do we need chemotherapy in low genomic/high clinical risk (er /her2-)?
-
4:20
adjuvant treatment guidelines in post-menopausal women with breast cancer
-
1:26
monarche: investigating adjuvant abemacicilib for high-risk hr breast cancer
-
1:37
dr. meisel on optimizing genomic assays in early-stage hr-positive, her2-negative breast cancer
-
1:38
unanswered questions in the use of adjuvant therapy in early breast cancer